Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Yinggelai Pharmaceutical is a specialized manufacturer of active pharmaceutical ingredients (APIs) and advanced chemical intermediates based in Pan'an, China. As a core subsidiary of the publicly traded Apeloa Pharmaceutical, the company plays a vital role in the group's small molecule production chain. Its core expertise lies in the large-scale synthesis of drugs for cardiovascular and anti-infective therapeutic areas. The company's manufacturing facilities are built to international standards and have received Good Manufacturing Practice (GMP) certifications from various regulatory bodies. Yinggelai provides both catalog APIs and custom manufacturing services (CMO) to a global clientele of pharmaceutical firms. By leveraging the research and development infrastructure of the Hengdian Group, the company maintains a competitive edge in complex chemical processing and quality assurance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江英格莱制药.